tivanisiran   Click here for help

GtoPdb Ligand ID: 14724

Synonyms: SYL-1001 | SYL1001
Compound class: Nucleic acid
Comment: Tivanisiran (SYL1001) is a small interfering RNA (siRNA) that is designed to target transient receptor potential cation channel subfamily V member 1 (TRPV1) mRNA to reduce channel abundance and therefore block TRPV1-mediated pain signals [1,3].
References
1. Baiula M, Spampinato S. (2021)
Experimental Pharmacotherapy for Dry Eye Disease: A Review.
J Exp Pharmacol, 13: 345-358. [PMID:33790661]
2. Mangwani-Mordani S, Goodman CF, Galor A. (2023)
Novel Treatments for Chronic Ocular Surface Pain.
Cornea, 42 (3): 261-271. [PMID:36729473]
3. Moreno-Montañés J, Bleau AM, Jimenez AI. (2018)
Tivanisiran, a novel siRNA for the treatment of dry eye disease.
Expert Opin Investig Drugs, 27 (4): 421-426. [PMID:29569947]